These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1246263)

  • 1. Letter: Correction of heart failure with treatment of hyperglycemia.
    N Engl J Med; 1976 Mar; 294(12):669-70. PubMed ID: 1246263
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter regarding article by von Lewinski et al, "Insulin causes [Ca2+]i-dependent and [Ca2+]i-independent positive inotropic effects in failing human myocardium".
    Hsu CH; Lin CI; Wei J
    Circulation; 2005 Dec; 112(25):e367; author reply e367. PubMed ID: 16365202
    [No Abstract]   [Full Text] [Related]  

  • 3. [Positive inotropic agents in the treatment of congestive heart failure].
    Hori M; Tamai J; Inoue M
    Kokyu To Junkan; 1987 Mar; 35(3):261-7. PubMed ID: 3296067
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of drugs affecting the heart.
    Jenkins WL; Clark DR
    J Am Vet Med Assoc; 1977 Jul; 171(1):85-92. PubMed ID: 328464
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in myocardial contractility after insulin treatment of circulatory insufficiency].
    Tsintsadze GI; Abzianidze AD; Megreladze II; Ordzhonikidze SP
    Ter Arkh; 1980; 52(7):112-3. PubMed ID: 6996195
    [No Abstract]   [Full Text] [Related]  

  • 6. Inotropic drugs in the management of congestive heart failure.
    Skelton CL
    J La State Med Soc; 1979 Apr; 131(4):109-17. PubMed ID: 458229
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of congestive heart failure to correction of hyperglycemia in the presence of diabetic nephropathy.
    Axelrod L
    N Engl J Med; 1975 Dec; 293(24):1243-5. PubMed ID: 1186804
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mechanisms and clinical profile of inotropic action of medicines for heart failure].
    Yazaki Y
    Kokyu To Junkan; 1989 Dec; 37(12):1271-7. PubMed ID: 2694254
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the cardiac effect of glucagon in patients with chronic failure of left ventricle (author's transl)].
    Kuhn H; Jaeschke M; Breithardt G; Loogen F
    Z Kardiol; 1978 Apr; 67(4):256-64. PubMed ID: 207029
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin and glucagon have insignificant inotropic properties in the normal and septic isolated rat heart.
    Markovitz LJ; Freund HR
    Curr Surg; 1984; 41(4):274-7. PubMed ID: 6383722
    [No Abstract]   [Full Text] [Related]  

  • 11. Inotropic drugs for treatment of the failing heart.
    Maskin CS; Le Jemtel TH; Sonnenblick EH
    Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucose, insulin, and potassium therapy for heart disease. History of GIK therapy.
    Kones RJ
    N Y State J Med; 1975 Aug; 75(9):1463-92. PubMed ID: 1097968
    [No Abstract]   [Full Text] [Related]  

  • 13. Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction.
    Zarich SW; Nesto RW
    Circulation; 2007 May; 115(18):e436-9. PubMed ID: 17485582
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic effect of dobutamine in patients with cardiac insufficiency].
    Delius W; Wirtzfeld A; Sebening H
    Verh Dtsch Ges Kreislaufforsch; 1976; 42():197-200. PubMed ID: 1007566
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
    Nikolaidis LA; Elahi D; Hentosz T; Doverspike A; Huerbin R; Zourelias L; Stolarski C; Shen YT; Shannon RP
    Circulation; 2004 Aug; 110(8):955-61. PubMed ID: 15313949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New catecholamines in clinical cardiovascular medicine.
    Leier CV
    Kardiol Pol; 1980; 23(9):721-5. PubMed ID: 7441942
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiovascular effects of glucagon].
    Lavarenne J
    Therapie; 1974; 29(2):161-84. PubMed ID: 4368071
    [No Abstract]   [Full Text] [Related]  

  • 18. Early abnormalities in myocardial cell function in experimental diabetes.
    Gøtzsche O
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 2():1-21. PubMed ID: 3017048
    [No Abstract]   [Full Text] [Related]  

  • 19. A model of controlled acute hyperglycemia in rats: Effects of insulin and glucagon-like peptide-1 analog.
    Saha JK; Xia J; Engle SK; Chen YF; Glaesner W; Jakubowski JA
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1159-64. PubMed ID: 16280413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diabetogenic effects of acute verapamil poisoning.
    Kline JA; Raymond RM; Schroeder JD; Watts JA
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):357-62. PubMed ID: 9266809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.